SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LEXG-Lexicon Genetics
LXRX 1.360-1.4%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who started this subject6/30/2003 9:21:13 AM
From: nigel bates  Read Replies (1) of 254
 
Deltagen, Inc. Files Voluntary Petition Under Chapter 11 of the United States Bankruptcy Code and Announces Delisting from the Nasdaq National Market

REDWOOD CITY, Calif., June 27 /PRNewswire-FirstCall/ -- Deltagen, Inc. (Nasdaq: DGEN - News) today announced that it has filed a voluntary petition under Chapter 11 of the federal Bankruptcy Code in the United States Bankruptcy Court in San Francisco, California.

Given actions taken by Lexicon Genetics, Incorporated and the inability to develop a sustainable revenue base that would support its operational needs, the second tranche of its bridge loan and its Series A preferred stock financing will not close. The Company was unable to obtain alternative sources of capital and, therefore, filed for bankruptcy while it had sufficient funds to explore dispositions of its assets and other reorganization transactions.

The Company also announced that it reduced its workforce to 28 employees.

Additionally, the Company announced the appointments of Mr. Larry Hill as Chief Executive Officer and Mr. Daniel Ratto as Chief Financial Officer. Mr. Hill will also serve as the Company's responsible individual during the Company's reorganization process. Mr. Hill is a principal with the firm Hickey & Hill, Inc., which specializes in corporate restructuring and management.

Additionally, Deltagen, Inc. announced it has been notified by the staff of the Nasdaq Stock Market that it has not regained compliance with Marketplace Rule 4450 (a)(5), related to the bid price of Deltagen's common stock, and that it is not in compliance with Rules 4350 (c) and 4350 (d)(2) related to independent director and audit committee requirements for continued listing on the Nasdaq Stock Market. The Company has decided not to appeal Nasdaq's delisting determination. As a result, Deltagen's securities will be delisted from the National Market at the opening of business on July 3, 2003. The Company believes that it should be eligible for trading on the OTC Bulletin Board. At least one market maker must make application to the NASD in order for trading to start on the OTC Bulletin Board...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext